Biotech Stocks Snooze Through Today’s Rally Awaiting Earnings This Week: Large Cap Biopharmaceuticals… ABBV, AMGN, BIIB, BMY, CELG…Update-2
Earnings Updates-2... 1/29 Large Cap Biopharmaceuticals Valuation Models of Large Cap Biotech to be Updated Next Week IBB trying to bottom above $262 down 21.8% YTD Abbvie (ABBV) mixed Q4, maintains 2016 outlook of $4.90-$5.10;Q4 IMBRUVICA of $343M;Merck Hep-C competition coming. ABBV off...
West Coast El Nino Update: Storms Stronger to North and Central Sierras in Heart of California Ski Country..Update-2–High and Dry
2/25/16 El Nino is busted for SoCal. Storms for Central and SoCal pushed out till March 8-10. High pressure blocking pattern for CA. Spring is here in February! 2/13/15 No Major Storms on Horizon-Possible Showers in San Francisco Next Week Look for for major precipitation by end of month but...
Biotech Rally Underway After Hitting 52 Week Low Today…Update-After Close
Can the Reversal Hold? IBB Rockets up 2.75% to 285.49 after hitting 52 week low today at 268.52. XBI up 4.22% to $55.09. Notable movers: Large caps: ABBV, ALXN, AMGN, REGN; BIIB down 0.19%, GILD lagging up only 0.72%. Mid-caps all green: ALKS,CLVS,SGEN,VRTX. All Rayno Small caps recover:...
Valuation Models for Large Cap Biopharma Stocks in a Bear Market
Valuation Models for Large Cap Biopharma Stocks Can Robust Drug Pipelines Deliver Future EPS Growth? This is a follow-up of our post on 1/8/16 Large Cap Biopharmaceuticals which looks at valuation models and stock performance of selected companies after the J.P.Morgan Healthcare Conference and...
J.P.Morgan Conference #2: Red Screen Distracts Biotech Investors…Update
Green Screen Alert Market Update...IBB up 4% today erasing most of Wednesday's Losses but we are still down 13.86% for the five day period. Nasdaq rallied 1.97%. Rayno Biopharma top winners: ABBV up 6.56%, ALXN up 5.93%, AMGN up 5.29%,BIIB up 4.98%, REGN up 4.25%,RXDX up 8.96%, SGEN up 2.26%...